Discover
NDRA
ENDRA Life Sciences Inc.
5.04
2 x 3.80
2 x 6.78
bid
ask
-
0.29
5.44%
2 @ 04:00 PM
5.04 +0.00 (0.00%)
| Ytd | 11.26% | |
| 1y | 47.80% |
4.96
day range
5.40
2.96
52 week range
11.96
| Open | 5.30 | Prev Close | 5.33 | Low | 4.96 | High | 5.40 | Mkt Cap | 6.40M |
| Vol | 7.15K | Avg Vol | 28.16K | EPS | -8.16 | P/E | N/A | Forward P/E | -0.02 |
| Beta | 0.74 | Short Ratio | 0.05 | Inst. Own | 0.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 5.05 | 200-d Avg | 4.93 | 1yr Est | 2625.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-15 | 2024-09 | -62.24 | -5.85 | 56.39 | 90.60% |
| 2024-08-14 | 2024-06 | 0 | -139.86 | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | -454.55 | N/A | N/A |
| 2024-03-28 | 2023-12 | 0 | -297.2 | N/A | N/A |
| 2023-11-14 | 2023-09 | 0 | -699.3 | N/A | N/A |
| 2023-08-14 | 2023-06 | 0 | -751.75 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-06-07 | Ascendiant Capital | Upgrade | Buy | Buy |
| 2023-03-31 | HC Wainwright & Co. | Upgrade | Buy |
Profile
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2021-08-25 | BASENESE LOUIS J. | Director | 49.07K | Sale |
| 2023-05-01 | DIGIANDOMENICO ANTHONY | Director | 102.43K | Purchase |
| 2020-04-08 | GAMBHIR SANJIV SAM | Director | 42.86K | Stock Award(Grant) |
| 2020-06-22 | HARSH MICHAEL JOHN | Director | 69.24K | Conversion of Exercise of derivative security |
| 2018-10-23 | LONGBOARD CAPITAL ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
| 2021-01-12 | MALOBERTI RENAUD BERTRAND | Officer | 1.58K | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Virtu Financial LLC | 2.30K | 12.88K | 0.43% |
| 2024-09-29 | Two Sigma Securities, LLC | 549.00 | 3.07K | 0.10% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 466.00 | 2.61K | 0.09% |
| 2024-09-29 | Two Sigma Investments, LP | 405.00 | 2.27K | 0.08% |
| 2024-09-29 | HRT Financial LP | 396.00 | 2.22K | 0.07% |
| 2024-09-29 | Jane Street Group, LLC | 320.00 | 1.79K | 0.06% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 35.00 | 195.00 | 0.01% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 23.00 | 128.00 | 0.00% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 5.00 | 27.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 35 | 2024-11-07 |
| 1 : 50 | 2024-08-20 |
| 1 : 20 | 2022-12-09 |